Work

A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group (GOG) study

Year: 2015

Type: article

Study design: Clinical Trial

Source: Gynecologic Oncology

DOI: 10.1016/j.ygyno.2015.04.018

Authors: D.P. Bender, M. Sill, H. Lankes, C.J. Darus, J. Delmore, J. Rotmensch, H.J. Gray, R.S. Mannel, J.M. Schilder, K.K. Leslie, H.D. Reyes, M. Hunter, C.K. McCourt, M. Samuelson

Institutions: University of Iowa Hospitals and Clinics, University of Kansas, Rush University Medical Center, University of Washington Medical Center, University of Oklahoma Health Sciences Center, Indiana University School of Medicine, University of Missouri, Washington University in St. Louis

Language: English

Topic: Endometrial and Cervical Cancer Treatments

Subfield: Obstetrics and Gynecology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W3021892562

FWCI: 0.694

Cites:

Cited by: 3

Related to: 10